Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys

被引:41
作者
Eslamboli, Andisheh [1 ]
Grundy, Robert I. [1 ]
Irving, Elaine A. [1 ]
机构
[1] GlaxoSmithKline Inc, Neurol & GI CEDD, Harlow CM19 5AW, Essex, England
关键词
Nogo-A; marmoset; stroke; ofigodendrocyte; plasticity;
D O I
10.1016/j.neulet.2006.08.056
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Nogo-A is a myelin-associated protein that has been shown to inhibit axonal sprouting after lesions to the CNS. Several studies have demonstrated that blocking the activity or expression of this inhibitor can induce structural and functional recovery after CNS lesions. However, there are limited and contradictory data on the expression of Nogo-A after CNS lesions. In the present study, marmoset monkeys received permanent occlusion of the middle cerebral artery (MCAo). Two, 3, or 4 months after the onset of injury brain sections were stained for Nogo-A protein. Two sham operated marmosets were included as a control. Nogo-A protein expression was quantified in white matter and grey matter in the areas adjacent to the lesion (or the equivalent areas in the intact side). At 2 months after injury, but not at 3 or 4 months, there was a significant increase in the number of oligodendrocytes that were Nogo-A immunopositive. This increase was observed in white matter structures that were adjacent to the lesion (e.g. corona radiate (CR)); but not in: white matter structures distal to the lesion (e.g. corpus callosum (CC)); cortical regions adjacent to the lesion; contralateral regions or in sham operated marmosets. These data suggest that Nogo-A levels are significantly increased within oligodendrocytes in areas adjacent to the lesion up to 2 months following cerebral ischeamia. Future studies will determine whether this offers the opportunity to promote plasticity by targeting Nogo-A weeks or months following stroke. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:89 / 93
页数:5
相关论文
共 25 条
[1]
Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy [J].
Bandtlow, CE ;
Dlaska, M ;
Pirker, S ;
Czech, T ;
Baumgartner, C ;
Sperk, G .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 20 (01) :195-206
[2]
VISUALIZATION OF OLIGODENDROCYTES AND ASTROCYTES IN THE INTACT RAT OPTIC-NERVE BY INTRACELLULAR INJECTION OF LUCIFER YELLOW AND HORSERADISH-PEROXIDASE [J].
BUTT, AM ;
RANSOM, BR .
GLIA, 1989, 2 (06) :470-475
[3]
New patterns of intracortical projections after focal cortical stroke [J].
Carmichael, ST ;
Wei, L ;
Rovainen, CM ;
Woolsey, TA .
NEUROBIOLOGY OF DISEASE, 2001, 8 (05) :910-922
[4]
Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 [J].
Chen, MS ;
Huber, AB ;
van der Haar, ME ;
Frank, M ;
Schnell, L ;
Spillmann, AA ;
Christ, F ;
Schwab, ME .
NATURE, 2000, 403 (6768) :434-439
[5]
Extensive cortical rewiring after brain injury [J].
Dancause, N ;
Barbay, S ;
Frost, SB ;
Plautz, EJ ;
Chen, DF ;
Zoubina, EV ;
Stowe, AM ;
Nudo, RJ .
JOURNAL OF NEUROSCIENCE, 2005, 25 (44) :10167-10179
[6]
Drug development for stroke: importance of protecting cerebral white matter [J].
Dewar, D ;
Yam, P ;
McCulloch, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) :41-50
[7]
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis [J].
Dupuis, L ;
de Aguilar, JLG ;
di Scala, F ;
Rene, F ;
de Tapia, M ;
Pradat, PF ;
Lacomblez, L ;
Seihlan, D ;
Prinjha, R ;
Walsh, FS ;
Meininger, V ;
Loeffler, JP .
NEUROBIOLOGY OF DISEASE, 2002, 10 (03) :358-365
[8]
Huber AB, 2002, J NEUROSCI, V22, P3553
[9]
Nogo-A expression in the intact and injured nervous system [J].
Hunt, D ;
Coffin, RS ;
Prinjha, RK ;
Campbell, G ;
Anderson, PN .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2003, 24 (04) :1083-1102
[10]
Irving EA, 1997, J CEREBR BLOOD F MET, V17, P612